Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Consumer Resources

Vaccines

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Low-Cost Meningitis Vaccine Cuts Cases In African Countries, Data Show

Burkina Faso, Mali and Niger recorded the lowest number of meningitis A cases in an epidemic season this year after the MenAfriVac vaccine was introduced, data from the WHO show, the nonprofit that helped develop the shot, Meningitis Vaccine Project (MVP), said on Thursday, Reuters reports.

Experts Discuss Impact Of New Vaccines On Global Health

This Malaria Policy Center blog post describes the event “Spurring health and wealth through medical breakthroughs,” during which Washington Post columnist and ONE Fellow Michael Gerson; John Lusingu, principal research scientist at the Tanzania National Institute for Medical Research and co-principal investigator in the RTS,S malaria vaccine trial in Tanzania…

Sabin Vaccine Institute, Texas Children’s Hospital, Baylor College Of Medicine To Create Tropical Disease Research School

Peter Hotez, chair of the Department of Microbiology, Immunology, and Tropical Medicine at George Washington University and president of Sabin Vaccine Institute, “will join the staffs of Texas Children’s Hospital and Baylor College of Medicine this summer, [and] will serve as founding dean of a new, as yet unnamed, tropical disease research school at Baylor,” the Houston Chronicle reports (Christian, 6/8).

GAVI Needs Strategic Plan For Future, CSIS Report Says

In this report from the Center for Strategic and International Studies, released ahead of the GAVI Alliance pledging conference, authors Lisa Carty, J. Stephen Morrison, Margaret Reeves, and Amanda Glassman write, “Its many achievements notwithstanding, GAVI still needs a strategic approach in the coming years if it is to deepen…

GSK, Crucell To Test Second-Generation Malaria Vaccine

GlaxoSmithKline and drug company Crucell, a division of Johnson & Johnson, will collaborate with the PATH Malaria Vaccine Initiative to test a second-generation malaria vaccine “within the next couple of months,” Reuters reports.